Screening of selective histone deacetylase inhibitors by proteochemometric modeling
<p>Abstract</p> <p>Background</p> <p>Histone deacetylase (HDAC) is a novel target for the treatment of cancer and it can be classified into three classes, i.e., classes I, II, and IV. The inhibitors selectively targeting individual HDAC have been proved to be the better candidate antitumor drugs. To...
Gespeichert in:
| Hauptverfasser: | , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
BMC
2012-08-01
|
| Schriftenreihe: | BMC Bioinformatics |
| Schlagworte: | |
| Online-Zugang: | http://www.biomedcentral.com/1471-2105/13/212 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|